Benzinga | Jan 27, 2022 05:42PM EST

Nurix Therapeutics: Q4 Earnings Insights

Nurix Therapeutics (NASDAQ:NRIX) reported its Q4 earnings results on Thursday, January 27, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Nurix Therapeutics missed estimated earnings by 23.19%, reporting an EPS of $-0.85 versus an estimate of $-0.69, which surprised analysts.

Revenue was up $707.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03, which was followed by a 1.16% increase in the share price the next day.

Here's a look at Nurix Therapeutics's past performance:



Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020EPS Estimate -0.62 -0.54 -0.46 -0.54EPS Actual -0.65 -0.60 -0.63 -0.51Revenue Estimate 8.57M 8.23M 7.94M 3.94MRevenue Actual 10.25M 7.09M 5.01M 6.69M

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.